Author:
Kateete David Patrick,Mbabazi Monica M.,Nakazzi Faith,Katabazi Fred A.,Kigozi Edgar,Ssengooba Willy,Nakiyingi Lydia,Namiiro Sharon,Okwera Alphonse,Joloba Moses L.,Muwonge Adrian
Abstract
AbstractInformation on microbiota dynamics in pulmonary tuberculosis (TB) in Africa is scarce. Here, we sequenced sputa from 120 treatment-naïve TB patients in Uganda, and investigated changes in microbiota of 30 patients with treatment-response follow-up samples. Overall, HIV-status and anti-TB treatment were associated with microbial structural and abundance changes. The predominant phyla were Bacteroidetes, Firmicutes, Proteobacteria, Fusobacteria and Actinobacteria, accounting for nearly 95% of the sputum microbiota composition; the predominant genera across time were Prevotella, Streptococcus, Veillonella, Haemophilus, Neisseria, Alloprevotella, Porphyromonas, Fusobacterium, Gemella, and Rothia. Treatment-response follow-up at month 2 was characterized by a reduction in abundance of Mycobacterium and Fretibacterium, and an increase in Ruminococcus and Peptococcus; month 5 was characterized by a reduction in Tannerella and Fusobacterium, and an increase in members of the family Neisseriaceae. The microbiota core comprised of 44 genera that were stable during treatment. Hierarchical clustering of this core’s abundance distinctly separated baseline (month 0) samples from treatment follow-up samples (months 2/5). We also observed a reduction in microbial diversity with 9.1% (CI 6–14%) of the structural variation attributed to HIV-status and anti-TB treatment. Our findings show discernible microbiota signals associated with treatment with potential to inform anti-TB treatment response monitoring.
Funder
European and Developing Countries Clinical Trials Partnership
Wellcome Trust
Africa Centre of Excellence in Materials, Product Development
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. World Health Organization. Global Tuberculosis Report 2021 (WHO, 2021).
2. World Health Organization, W. H. O. The top 10 causes of death. 2014. Fact sheet (2018).
3. Global Tuberculosis Community Advisory Board. TB infections hit 90,000 a year in Uganda, overtake HIV rates. https://www.tbonline.info/posts/2019/3/20/tb-infections-hit-90000-year-uganda-overtake-hiv-r/ (2019).
4. Theron, G. et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. The Lancet 383, 424–435 (2014).
5. Wipperman, M. F. et al. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after treatment is completed. Sci. Rep. 7, 1–11 (2017).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献